Transgene Biotek Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 0.016949 million. Revenue was INR 0.455419 million compared to INR 0.43847 million a year ago. Net loss was INR 26.03 million compared to INR 26.73 million a year ago. Basic loss per share from continuing operations was INR 0.34 compared to INR 0.35 a year ago. Diluted loss per share from continuing operations was INR 0.34 compared to INR 0.35 a year ago. For the six months, sales was INR 0.016949 million. Revenue was INR 0.893889 million compared to INR 0.87694 million a year ago. Net loss was INR 52.15 million compared to INR 53.1 million a year ago. Basic loss per share from continuing operations was INR 0.69 compared to INR 0.7 a year ago. Diluted loss per share from continuing operations was INR 0.69 compared to INR 0.7 a year ago.